256 related articles for article (PubMed ID: 25822764)
21. PHOX2B is a novel and specific marker for minimal residual disease testing in neuroblastoma.
Stutterheim J; Gerritsen A; Zappeij-Kannegieter L; Kleijn I; Dee R; Hooft L; van Noesel MM; Bierings M; Berthold F; Versteeg R; Caron HN; van der Schoot CE; Tytgat GA
J Clin Oncol; 2008 Nov; 26(33):5443-9. PubMed ID: 18838715
[TBL] [Abstract][Full Text] [Related]
22. Phenotypic characterization of non-haemopoietic small cell tumours of childhood with monoclonal antibodies to leucocytes, epithelial cells and cytoskeletal proteins.
Pilkington GR; Pallesen G
Histopathology; 1989 Apr; 14(4):347-57. PubMed ID: 2544500
[TBL] [Abstract][Full Text] [Related]
23. PAX immunoreactivity identifies alveolar rhabdomyosarcoma.
Sullivan LM; Atkins KA; LeGallo RD
Am J Surg Pathol; 2009 May; 33(5):775-80. PubMed ID: 19145202
[TBL] [Abstract][Full Text] [Related]
24. Examination of PHOX2B in adult neuroendocrine neoplasms reveals relatively frequent expression in phaeochromocytomas and paragangliomas.
Lee JP; Hung YP; O'Dorisio TM; Howe JR; Hornick JL; Bellizzi AM
Histopathology; 2017 Oct; 71(4):503-510. PubMed ID: 28464318
[TBL] [Abstract][Full Text] [Related]
25. Identification of novel pathways and molecules able to down-regulate PHOX2B gene expression by in vitro drug screening approaches in neuroblastoma cells.
Di Zanni E; Fornasari D; Ravazzolo R; Ceccherini I; Bachetti T
Exp Cell Res; 2015 Aug; 336(1):43-57. PubMed ID: 25882494
[TBL] [Abstract][Full Text] [Related]
26. A study of gata3 and phox2b expression in tumors of the autonomic nervous system.
Nonaka D; Wang BY; Edmondson D; Beckett E; Sun CC
Am J Surg Pathol; 2013 Aug; 37(8):1236-41. PubMed ID: 23715162
[TBL] [Abstract][Full Text] [Related]
27. NKX2.2 immunohistochemistry in the distinction of Ewing sarcoma from cytomorphologic mimics: Diagnostic utility and pitfalls.
Russell-Goldman E; Hornick JL; Qian X; Jo VY
Cancer Cytopathol; 2018 Nov; 126(11):942-949. PubMed ID: 30376220
[TBL] [Abstract][Full Text] [Related]
28. PAX2 expression in Wilms tumors and other childhood neoplasms.
Davis JL; Matsumura L; Weeks DA; Troxell ML
Am J Surg Pathol; 2011 Aug; 35(8):1186-94. PubMed ID: 21730820
[TBL] [Abstract][Full Text] [Related]
29. Phox2B mutations and the Delta-Notch pathway in neuroblastoma.
van Limpt V; Chan A; Schramm A; Eggert A; Versteeg R
Cancer Lett; 2005 Oct; 228(1-2):59-63. PubMed ID: 16084642
[TBL] [Abstract][Full Text] [Related]
30. Bone marrow of neuroblastoma patients shows downregulation of CXCL12 expression and presence of IFN signature.
Scaruffi P; Morandi F; Gallo F; Stigliani S; Parodi S; Moretti S; Bonassi S; Fardin P; Garaventa A; Zanazzo G; Pistoia V; Tonini GP; Corrias MV
Pediatr Blood Cancer; 2012 Jul; 59(1):44-51. PubMed ID: 21994039
[TBL] [Abstract][Full Text] [Related]
31. Detection of microscopic neuroblastoma in marrow by histology, immunocytology, and reverse transcription-PCR of multiple molecular markers.
Cheung IY; Barber D; Cheung NK
Clin Cancer Res; 1998 Nov; 4(11):2801-5. PubMed ID: 9829745
[TBL] [Abstract][Full Text] [Related]
32. [Prognostic value of the determination of bone marrow lesion in patients with neuroblastoma based on the gene PHOX2B and TH expression].
Druĭ AE; Shorikov EV; Tsaur GA; Popov AM; Tuponogov SN; Savel'ëv LI; Tsvirenko SV; Fechina LG
Vopr Onkol; 2014; 60(2):57-62. PubMed ID: 24919263
[TBL] [Abstract][Full Text] [Related]
33. Diffuse and strong cyclin D1 immunoreactivity in clear cell sarcoma of the kidney.
Mirkovic J; Calicchio M; Fletcher CD; Perez-Atayde AR
Histopathology; 2015 Sep; 67(3):306-12. PubMed ID: 25556515
[TBL] [Abstract][Full Text] [Related]
34. ppGalNAc-T13: a new molecular marker of bone marrow involvement in neuroblastoma.
Berois N; Blanc E; Ripoche H; Mergui X; Trajtenberg F; Cantais S; Barrois M; Dessen P; Kågedal B; Bénard J; Osinaga E; Raguénez G
Clin Chem; 2006 Sep; 52(9):1701-12. PubMed ID: 16873292
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemistry of primary malignant neuroepithelial tumors of the kidney: a potential source of confusion? A study of 30 cases from the National Wilms Tumor Study Pathology Center.
Ellison DA; Parham DM; Bridge J; Beckwith JB
Hum Pathol; 2007 Feb; 38(2):205-11. PubMed ID: 17134738
[TBL] [Abstract][Full Text] [Related]
36. Event-free survival of infants and toddlers enrolled in the HR-NBL-1/SIOPEN trial is associated with the level of neuroblastoma mRNAs at diagnosis.
Corrias MV; Parodi S; Tchirkov A; Lammens T; Vicha A; Pasqualini C; Träger C; Yáñez Y; Dallorso S; Varesio L; Luksch R; Laureys G; Valteau-Couanet D; Canete A; Pöetschger U; Ladenstein R; Burchill SA
Pediatr Blood Cancer; 2018 Jul; 65(7):e27052. PubMed ID: 29603574
[TBL] [Abstract][Full Text] [Related]
37. miR-204 mediates post-transcriptional down-regulation of PHOX2B gene expression in neuroblastoma cells.
Bachetti T; Di Zanni E; Ravazzolo R; Ceccherini I
Biochim Biophys Acta; 2015 Aug; 1849(8):1057-65. PubMed ID: 26145533
[TBL] [Abstract][Full Text] [Related]
38. Paranuclear blue inclusions in metastatic undifferentiated small cell carcinoma in the bone marrow.
Wittchow R; Laszewski M; Walker W; Dick F
Mod Pathol; 1992 Sep; 5(5):555-8. PubMed ID: 1285355
[TBL] [Abstract][Full Text] [Related]
39. NKX3.1 a useful marker for mesenchymal chondrosarcoma: An immunohistochemical study.
Syed M; Mushtaq S; Loya A; Hassan U
Ann Diagn Pathol; 2021 Feb; 50():151660. PubMed ID: 33302222
[TBL] [Abstract][Full Text] [Related]
40. Detection of neuroblastoma cells during clinical follow up: advanced flow cytometry and rt-PCR for tyrosine hydroxylase using both conventional and real-time PCR.
Esser R; Glienke W; Bochennek K; Erben S; Quaiser A; Pieper C; Eggert A; Schramm A; Astrahantseff K; Hansmann ML; Schwabe D; Klingebiel T; Koehl U
Klin Padiatr; 2011 Nov; 223(6):326-31. PubMed ID: 22095188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
